Outcome
    Moderate Evidence

    Saw Palmetto for DHT Reduction

    Saw palmetto has little measurable effect on circulating DHT at standard doses.

    Overview

    Saw palmetto has little measurable effect on circulating DHT at standard doses.

    Verdict

    Insufficient evidence

    How It Works

    Lipid extracts inhibit 5-alpha-reductase in vitro, but tissue concentrations achieved orally appear too low to meaningfully suppress the enzyme.

    Dosing & Protocol

    Typical dose

    Recommended dose
    320 mg/day of liposterolic saw palmetto extract; measurable DHT reduction has not been consistently demonstrated
    Expected timeframe
    Not established

    Protocol

    form
    Liposterolic Serenoa repens extract standardised to 85-95% fatty acids and sterols; Permixon was used in the main trials
    duration
    Trials measuring hormonal endpoints ran 6-12 months
    co factor
    Take with food to reduce gastrointestinal upset. Evidence is insufficient. Saw palmetto inhibits 5-alpha-reductase in vitro, which is the mechanistic claim, but human data are inconsistent: the large NIH-funded STEP and CAMUS trials found no significant change in serum or intraprostatic DHT at doses up to 960 mg/day, while some smaller studies report modest reductions in intraprostatic DHT. By contrast finasteride reduces serum DHT by around 70% and dutasteride by over 90%. Whatever saw palmetto does to DHT, it is a fraction of what the drugs do and it has not translated into clinical benefit.
    titration
    Not applicable - 320 mg/day is the standard studied dose and higher doses have not been tested for hormonal endpoints
    starting dose
    160 mg twice daily with food if used, which is the dose studied for prostate symptoms

    Evidence

    What the studies say

    Trials measuring serum androgens generally find no significant reduction in DHT, in contrast to pharmaceutical 5-alpha-reductase inhibitors, which lower DHT by 60-90 percent.

    Comparitive effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: a two-year study

    Score: 5/10
    2012
    rct
    n=100

    Rossi A

    38% of patients treated with Serenoa repens had an increase in hair growth, while 68% of those treated with finasteride noted an improvement.

    View source

    Safety

    Caveats

    The comparison with the pharmaceutical 5-alpha-reductase inhibitors is instructive: finasteride and dutasteride reduce DHT by 70-90% and produce measurable clinical effects on prostate volume and hair, and saw palmetto at triple the usual dose did not significantly change DHT in the largest well-conducted trials. Lowering DHT is also not a health goal in itself - it is relevant only through prostate symptoms or androgenetic alopecia, both of which have proper treatments. Safety of saw palmetto: generally well tolerated, with mild gastrointestinal upset, nausea and headache the main effects. It has weak antiplatelet activity, with case reports of bleeding, so use caution with warfarin, direct oral anticoagulants, aspirin and antiplatelet drugs, and stop two weeks before surgery. Rare cases of liver injury and pancreatitis have been reported. Critically, it is contraindicated in pregnancy and in women who may become pregnant, since antiandrogens can cause genital malformation in a male fetus, and it should not be handled by pregnant women. It may theoretically lower PSA, which can mask prostate cancer detection - tell your doctor if you are taking it before a PSA test.

    Less likely to help if

    Everyone - the large trials found no meaningful DHT change.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.